Publications by authors named "Sandip Panicker"

Claim this Profile
S
Signal regulating proteins (SIRPs) participate in sarcoidosis granuloma formation by promoting immune cell aggregation.
Marc A Judson, Mark W Julian, Llewellyn Foulke, Sandip Panicker, Soe H Arker

Respir Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal Regulatory Protein α Expression in Systemic Vasculitis.
Shubhasree Banerjee, Eileen Rose, Sandip Panicker, John Dugan, Nader Khalidi

ACR Open Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb.
Vaishnavi Rajagopal, Nina Leksa, Ronald Gorham, Siddharth Jindal, Soumya Nair, Sandip Panicker

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-C1s humanized monoclonal antibody SAR445088: A classical pathway complement inhibitor specific for the active form of C1s.
Ken T Simmons, Joanne Chan, Sami Hussain, Eileen L Rose, Kate Markham, Sandip Panicker

Clin Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.
John W Rumsey, Case Lorance, Max Jackson, Trevor Sasserath, Christopher W McAleer, Sandip Panicker

Adv Ther (Weinh)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid.
Patricia Colchete Freire, Cristina Herraez Muñoz, Ulla Derhaschnig, Christian Schoergenhofer, Christa Firbas, Sandip Panicker

J Invest Dermatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against and .
Lisa A Lewis, Sandip Panicker, Rosane B DeOliveira, Graham C Parry, Sanjay Ram

Immunohorizons· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
Ulrich Jäger, Shirley D'Sa, Christian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Sandip Panicker

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.
Pavel A Nikitin, Eileen L Rose, Tony S Byun, Graham C Parry, Sandip Panicker

J Immunol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway.
Johann Bartko, Christian Schoergenhofer, Michael Schwameis, Christa Firbas, Martin Beliveau, Sandip Panicker

Clin Pharmacol Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies.
Anika Kasprick, Maike M Holtsche, Eileen L Rose, Sami Hussain, Enno Schmidt, Sandip Panicker

J Invest Dermatol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.
Jakob Mühlbacher, Bernd Jilma, Markus Wahrmann, Johann Bartko, Farsad Eskandary, Sandip Panicker

Transplantation· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003.
Nicole M Valenzuela, Kimberly A Thomas, Arend Mulder, Graham C Parry, Sandip Panicker

Transplantation· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor.
Ellinor I B Peerschke, Sandip Panicker, James Bussel

Br J Haematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.
Lucrezia Colonna, Graham C Parry, Sandip Panicker, Keith B Elkon

Clin Immunol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.
Ju Shi, Eileen L Rose, Andrew Singh, Sami Hussain, Nancy E Stagliano, Sandip Panicker

Blood· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions.
Gang Chen, Sandip Panicker, Kai-Yeung Lau, Subramaniam Apparsundaram, Vaishali A Patel

Mol Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.
Joel R Gever, Rothschild Soto, Robert A Henningsen, Renee S Martin, David H Hackos, Sandip Panicker

Br J Pharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse.
Sandip Panicker, Keith Brown, Roger A Nicoll

Proc Natl Acad Sci U S A· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time imaging of discrete exocytic events mediating surface delivery of AMPA receptors.
Guillermo A Yudowski, Manojkumar A Puthenveedu, Dmitri Leonoudakis, Sandip Panicker, Kurt S Thorn

J Neurosci· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal structural rearrangement of the cytoplasmic pore during activation of the 5-HT3A receptor.
Sandip Panicker, Hans Cruz, Christine Arrabit, Ka Fai Suen, Paul A Slesinger

J Biol Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for a centrally located gate in the pore of a serotonin-gated ion channel.
Sandip Panicker, Hans Cruz, Christine Arrabit, Paul A Slesinger

J Neurosci· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis